Dynamic quotes: Off
|
ETFs with ENDP as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 4.72% | SPDR S&P Pharmaceuticals ETF (XPH) | +14.91 (27.05%) |
| 3.23% | PowerShares Dynamic Pharmaceuticals (PJP) | +9.26 (27.19%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
On May 23, 2012, we changed our name from Endo Pharmaceuticals Holdings Inc. to Endo Health Solutions Inc., which we refer to herein as “Endo”, “we”, “us”, or the “Company”. Concurrently with this change, the Company also changed the names of its business segments. Effective May 23, 2012, the names of our business segments are Endo Pharmaceuticals (formerly Branded Pharmaceuticals), Qualitest (formerly Generics), AMS (formerly Devices) and HealthTronics (formerly Services). Financial information for our segments is included in Note 6. Segment Results in the Consolidated Financial Statements, included in Part IV, Item 15. of this report "Exhibits, Financial Statement Schedules". Endo is a U.S. based, specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. ... More ...
Analyst Info |
|
| Annual EPS Est: | $5.02 |
| Quarterly EPS Est: | 1.17 |
| PEG Ratio: | 1.49 |
|
Mean Recommendation: View Summary / View All |
2.67 |
Data is provided by Zacks Investment Research
